U.S. flag

An official website of the United States government

NM_020070.4(IGLL1):c.420T>C (p.Phe140=) AND not provided

Germline classification:
Likely benign (2 submissions)
Last evaluated:
Apr 1, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000757400.25

Allele description [Variation Report for NM_020070.4(IGLL1):c.420T>C (p.Phe140=)]

NM_020070.4(IGLL1):c.420T>C (p.Phe140=)

Gene:
IGLL1:immunoglobulin lambda like polypeptide 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q11.23
Genomic location:
Preferred name:
NM_020070.4(IGLL1):c.420T>C (p.Phe140=)
HGVS:
  • NC_000022.11:g.23573488A>G
  • NG_009791.1:g.11821T>C
  • NM_001369906.1:c.423T>C
  • NM_020070.4:c.420T>CMANE SELECT
  • NM_152855.3:c.*49T>C
  • NP_001356835.1:p.Phe141=
  • NP_064455.1:p.Phe140=
  • LRG_69:g.11821T>C
  • NC_000022.10:g.23915675A>G
  • NM_020070.3:c.420T>C
  • p.Phe140Phe
Links:
dbSNP: rs1064423
NCBI 1000 Genomes Browser:
rs1064423
Molecular consequence:
  • NM_152855.3:c.*49T>C - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001369906.1:c.423T>C - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_020070.4:c.420T>C - synonymous variant - [Sequence Ontology: SO:0001819]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000885604ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Likely benign
(Apr 1, 2018)
germlineclinical testing

Citation Link,

SCV001746440CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Likely benign
(Apr 1, 2021)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes1not providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV000885604.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.420T>C; p.Phe140Phe variant (rs1064423) does not alter the amino acid sequence of the IGLL1 protein and computational splice site prediction algorithms do not predict a change in the nearest splice site or creation of a cryptic splice site. This variant has not been reported in association with antibody deficiency in medical literature or in gene specific variation databases. This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.04% (identified on 106 out of 276,448 chromosomes). Based on the available information, the c.420T>C variant is likely to be benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV001746440.14

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Apr 15, 2024